Human Genome Epidemiology Literature Finder
Records 1 - 5 (of 5 Records) |
Query Trace: Adenocarcinoma and CCDC6[original query] |
---|
Broad, Hybrid Capture-Based Next-Generation Sequencing Identifies Actionable Genomic Alterations in Lung Adenocarcinomas Otherwise Negative for Such Alterations by Other Genomic Testing Approaches. Clinical cancer research : an official journal of the American Association for Cancer Research 2015 1 21 (16): 3631-9. Drilon Alexander, Wang Lu, Arcila Maria E, Balasubramanian Sohail, Greenbowe Joel R, Ross Jeffrey S, Stephens Phil, Lipson Doron, Miller Vincent A, Kris Mark G, Ladanyi Marc, Rizvi Naiyer |
Genomic profiling of lung adenocarcinoma patients reveals therapeutic targets and confers clinical benefit when standard molecular testing is negative. Oncotarget 2016 Mar . Lim Sun Min, Kim Eun Young, Kim Hye Ryun, Ali Siraj M, Greenbowe Joel R, Shim Hyo Sup, Chang Hyun, Lim Seungtaek, Paik Soonmyung, Cho Byoung Ch |
Molecular and clinicopathological characteristics of ROS1-rearranged non-small-cell lung cancers identified by next-generation sequencing. Molecular oncology 2020 Sep . Cui Meiying, Han Yuchen, Li Pan, Zhang Jianying, Ou Qiuxiang, Tong Xiaoling, Zhao Ruiying, Dong Nan, Wu Xue, Li Wencai, Jiang Guozho |
Histomolecular Resistance Mechanisms to First-Line Osimertinib in EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Multicentric Retrospective French Study. Targeted oncology 2022 9 17 (6): 675-682. Akli Assya, Girard Nicolas, Fallet Vincent, Rousseau-Bussac Gaelle, Gounant Valérie, Friard Sylvie, Trédaniel Jean, Dujon Cécile, Wislez Marie, Duchemann Boris, Giroux-Leprieur Etien |
Durable response to low-dose pralsetinib in a renal insufficient patient with NSCLC harboring concurrent CCDC6-RET, LINCO1264-RET, and SEMA5A-RET fusions: A case report. Medicine 2022 12 101 (47): e31480. Gu Linping, Ji Wenxiang, Xu Yunhua, Han Yuchen, Jian Ho |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: